Gaetan Despres
Paris, 75013, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Modulation of Brain Cholesterol Metabolism through CYP46A1 Overexpression for Rett Syndrome.
Journal: Pharmaceutics
Published: May 02, 2024
Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasis.
Journal: Journal of hepatology
Published: October 03, 2022
Dendrogenin A synergizes with Cytarabine to Kill Acute Myeloid Leukemia Cells In Vitro and In Vivo.
Journal: Cancers
Published: May 21, 2020
CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease.
Journal: Brain : a journal of neurology
Published: October 30, 2018
Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia.
Journal: Acta neuropathologica
Published: October 02, 2018
Dendrogenin A drives LXR to trigger lethal autophagy in cancers.
Journal: Nature communications
Published: April 10, 2017
CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.
Journal: Brain : a journal of neurology
Published: April 10, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026